tiprankstipranks
Trending News
More News >
Fennec Pharmaceuticals (FENC)
NASDAQ:FENC
US Market

Fennec Pharmaceuticals (FENC) Financial Statements

Compare
247 Followers

Fennec Pharmaceuticals Financial Overview

Fennec Pharmaceuticals's market cap is currently $263.72M. The company's EPS TTM is $-0.02040444; its P/E ratio is -32.18; Fennec Pharmaceuticals is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 47.54M$ 21.25M$ 1.53M$ 0.00$ 170.00K
Gross Profit$ 44.35M$ 19.99M$ 1.45M$ 0.00$ 170.00K
Operating Income$ 2.57M$ -12.77M$ -22.59M$ -17.22M$ -17.89M
EBITDA$ 4.80M$ -12.65M$ -22.74M$ -17.18M$ -17.98M
Net Income$ -436.00K$ -16.05M$ -23.86M$ -17.46M$ -18.11M
Balance Sheet
Cash & Short-Term Investments$ 26.63M$ 13.27M$ 23.77M$ 21.10M$ 30.34M
Total Assets$ 44.95M$ 26.86M$ 26.94M$ 22.41M$ 31.42M
Total Debt$ 19.34M$ 30.95M$ 24.90M$ 4.99M$ 0.00
Net Debt$ -7.29M$ 17.68M$ 1.13M$ -16.11M$ -30.34M
Total Liabilities$ 50.82M$ 38.49M$ 29.51M$ 6.64M$ 2.35M
Stockholders' Equity$ -5.87M$ -11.62M$ -2.57M$ 15.77M$ 29.07M
Cash Flow
Free Cash Flow$ 26.98M$ -17.14M$ -18.06M$ -14.22M$ -15.60M
Operating Cash Flow$ 26.98M$ -17.14M$ -18.06M$ -14.22M$ -15.60M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ -13.62M$ 6.64M$ 20.73M$ 4.98M$ 32.29M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

Fennec Pharmaceuticals Debt to Assets

Fennec Pharmaceuticals Cash Flow

Fennec Pharmaceuticals Forecast EPS vs Actual EPS